Your email has been successfully added to our mailing list.

×
0 0 0.000620219144097605 0.000620219144097605 -0.000689132382330606 0.000344566191165205 0.00785610915856927 -0.0110261181172905
Stock impact report

Johnson & Johnson: Buy This Bargain Before It's Gone [Seeking Alpha]

Johnson & Johnson (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
Company Research Source: Seeking Alpha
Tecvayli sales were $133 million in the first quarter of 2024, up 111% year over year. Despite increased competition in the global autoimmune disease therapeutics market, the sales growth rate of most of its blockbusters has pleasantly surprised me. As a result, I am upgrading Johnson & Johnson's rating from 'Buy' to 'Strong Buy'. Johnson & Johnson ( NYSE: JNJ ), headquartered in New Brunswick, New Jersey, is one of the largest pharmaceutical companies in the world and also holds a leading position in the oncology drugs market. Investment thesis Since Recommended For You Recommended For You About JNJ Stock Related Stocks Trending Analysis Trending News Show less Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
JNJ alerts

from News Quantified
Opt-in for
JNJ alerts

from News Quantified